This double-blinded, randomized, crossover study evaluated the safety and effectiveness of 20 mL/kg aliquots of packed red blood cell (PRBC) transfusions versus 15 mL/kg aliquot transfusions in very low birth weight (VLBW) infants with anemia. The study enrolled 22 hemodynamically stable VLBW infants requiring PRBC transfusions, with a mean gestational age of 25.7 ± 2.2 weeks and birth weight of 804 ± 261 g. Each infant was randomized to receive one of two treatment sequences: 15 mL/kg followed by 20 mL/kg or 20 mL/kg followed by 15 mL/kg. The infants were monitored during and after transfusions, and the efficacy and safety of the treatments were evaluated. Infants had higher posttransfusion hemoglobin (13.2 g/dL vs 11.8 g/dL, P < 0.01) and hematocrit levels (38.6 g/dL vs 34.4 g/dL, P < 0.01) following 20 mL/kg PRBC transfusions when compared to 15 mL/kg transfusions. There were no differences in the incidence of tachypnea, hepatomegaly, edema, hypoxia, necrotizing enterocolitis, or vital sign instability between groups. In conclusion, high-volume PRBC transfusions (20 mL/kg) were associated with higher posttransfusion hemoglobin and hematocrit levels but no adverse effects. Higher-volume transfusions may reduce the need for multiple transfusions and therefore the number of donors the infant is exposed to.
A nnually, more than 60,000 infants are born in the United States with a birth weight ≤1500 g. Th ese very low birth weight (VLBW) infants are at risk of serious complications, including anemia of prematurity. Anemia of prematurity is caused by ineff ective hematopoiesis and iatrogenic blood loss through frequent phlebotomy and is exacerbated by low iron stores. Anemia leads to inadequate oxygen delivery to tissues and poor growth. As a result, VLBW infants are a heavily transfused population, accounting for nearly three-quarters of neonatal red blood cell transfusions ( 1 -3 ) .
Although blood transfusions are considered essential, there are concerns related to infection risk, the safety of directed donations, and refusal based on religious beliefs ( 4 ). Limiting packed red blood cell (PRBC) transfusions may reduce transfusion-associated infection and iron overload ( 5 ) . Transfusion guidelines are based on expert opinion, rather than evidence, and therefore vary among hospitals, with some units favoring restrictive guidelines and others more liberal guidelines ( 6 -8 ) .
Although the traditional volume of PRBC transfusions ranges from 10 to 20 mL/kg ( 9 ), there is still considerable debate 
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Lea H. Mallett , PhD, Vinayak P. Govande , MD, Ashita Shetty, MD, and Madhava R. Beeram, MD regarding the optimal volume of transfusion. In a systematic review, only four trials, with 146 infants, compared transfusion volumes of 10 versus 20 mL/kg ( 3 ). Th ese studies showed no diff erences in neonatal outcomes, but the number of patients in each study was small and markedly limited the power of these studies to detect a diff erence. Th e purpose of this study was to evaluate the safety and eff ectiveness of using larger-volume aliquots for PRBC transfusions in preterm VLBW infants.
METHODS
Th is study was conducted at McLane Children's Hospital, Baylor Scott & White Health, in Temple, Texas. VLBW infants admitted to the neonatal intensive care unit that were expected to require at least two PRBC transfusions after 48 hours of life were eligible for enrollment. Patients with any of the following were excluded: birth weight <500 g, congenital heart defects, or hemodynamic instability (defi ned as pulse >180 beats/min and capillary refi ll >3 sec). Th is was a randomized, double-blind, crossover study. Informed parental consent was obtained for eligible patients and then each infant was randomized, using a random number generator, to one of the two treatment sequences: 15 mL/kg transfusion followed by 20 mL/kg transfusion or 20 mL/kg transfusion followed by 15 mL/kg transfusion. For both treatment groups, the blood was transfused intravenously over 3 hours.
The blood product utilized for this study consisted of component aliquot bags with a hematocrit of 60%, stored in Nutricel AS-3 (Haemonetics, Pittsburgh, PA), which contains dextrose, adenine, monobasic sodium phosphate, and sodium chloride transfused via sterile tubing. All PRBC transfusions were cytomegalovirus negative, leukocyte reduced, O-type with the same Rh type as the infant.
Patients were enrolled over a 24-month period (January 2000-December 2002). Clinical and demographic information, including the Score for Neonatal Acute Physiology (SNAP-II), was collected ( 10 ) . Th e need for transfusion was based on current transfusion guidelines but ultimately determined by the attending neonatologist. Before transfusion, the following specifi c parameters were assessed among both treatment groups: 1) respiratory distress employing the Silverman Score ( 11 ); 2) presence of edema or hepatomegaly; and 3) vital signs (heart rate, respiratory rate, blood pressure, and oxygen saturations). Vital signs were monitored hourly during and up to 6 hours after transfusion. Hematocrit, hemoglobin, and red blood cell counts were also collected 1 hour before transfusion and for 3 hours after transfusion.
Th e primary outcome was posttransfusion change in hemoglobin and hematocrit in infants following both PRBC transfusion treatment sequences. Secondary outcomes included vital sign instability, edema or hepatomegaly, and respiratory distress. Statistical analyses were performed using SAS Version 8.2 (SAS Institute, Cary, NC). All data were compared using analysis of variance for a crossover design ( 12 ) . Th e traditional defi nition of a P value of 0.05 or less for statistical signifi cance was applied ( 13 ) .
RESULTS
Twenty-four infants were enrolled in the study; 2 parents withdrew consent prior to randomization, and the remaining 22 patients were randomized into one of the two treatment sequences: 15 mL/kg transfusion followed by 20 mL/kg transfusion or 20 mL/kg transfusion followed by 15 mL/kg transfusion. Seven patients were discharged after receiving only the fi rst transfusion and 15 patients received 2 transfusions. Demographic and clinical characteristics of study infants by treatment group are presented in Table 1 . Th e median number of days between the fi rst and second transfusion for all patients was 8 days (range, 1-22).
As shown in Table 2 , infants from both sequence groups had higher posttransfusion hemoglobin (13.2 vs 11.8 g/dL, P < 0.01) and hematocrit levels (38.6 vs 34.4 g/dL, P < 0.01) following 20 mL/kg PRBC transfusions when compared to 15 mL/kg transfusions. Th ere were no signifi cant diff erences in the incidence of hepatomegaly, edema, respiratory distress, or abnormal vital signs during the 20 mL/kg transfusions compared to the 15 mL/kg transfusions. One patient (5%) had hepatomegaly following a transfusion of 15 mL/kg. Four patients (18%) had edema following transfusion, one after 15 mL/kg and three after 20 mL/kg transfusions. Necrotizing enterocolitis developed in one patient (5%), who received 20 mL/kg followed by 15 mL/kg 2 days after the two transfusions were completed, requiring surgical intervention. Th e infant survived to discharge.
DISCUSSION
Our findings support the efficacy and safety of higher-volume (20 mL/kg) PRBC transfusions, currently supported by four similar studies. Th e larger transfusion volumes resulted in signifi cantly higher hemoglobin and hematocrit values when compared to 15 mL/kg transfusions. Infants tolerated the higher volumes well, with no signifi cant diff erences in the incidence of respiratory distress, hepatomegaly, peripheral edema, hypoxia, necrotizing enterocolitis, or vital sign insatiability. Th ese fi ndings are consistent with a previous study by Wong et al in 2005 comparing 20 mL/kg with 15 mL/kg PRBC transfusions. Th e randomized crossover design and the addition of the SNAP-II score were strengths of this study. By randomizing the sequence and having each infant serve as his or her own control, the observed changes in hemoglobin and hematocrit were not biased by order of transfusion or by infant idiosyncrasies. However, our study had several limitations. First, our study had a limited sample size, which may have impacted our ability to detect safety signal. However, our fi ndings add to the paucity of data in this area. Second, our results may not be generalizable to other centers with diff erent transfusion practices. Finally, the Silverman score is subject to ascertainment bias. Th erefore, further study in this area may address some of these limitations and expand its scope.
Our fi ndings suggest that higher-volume PRBC transfusions lead to higher posttransfusion hemoglobin and hematocrit volumes without increasing acute complications. Th ese results suggest a way to potentially decrease or eliminate the need for multiple transfusions and the number of donors the infant is exposed to, thereby decreasing risk. Prospective validation of this practice, with larger studies, is needed to determine long-term benefi ts, safety profi le, and cost-eff ectiveness.
